ArticleJAMA pediatrics2017
Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States.
Article in JAMA pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
92 citing papers in PubMed, 2 syntheses or guidelines pooled it, 357 citations in OpenAlex.
- Pooled it
- Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care.Preventive medicine · 2022Pooled it
- A Critical Health Literacy Podcast to Counter Health Misinformation at Scale: Randomized Controlled Trial.JMIR public health and surveillance · 2026Trial
- The syndemic nexus: How vaccine hesitancy and COVID-19 interact to influence vaccine uptake among university students.Human vaccines & immunotherapeutics · 2026Article
- Characteristics of COVID-19 vaccine hesitancy in university students: Methodological insights from a syndemic perspective.Human vaccines & immunotherapeutics · 2026Article
- The 2025 measles outbreak in Texas.BMC infectious diseases · 2026Article
- Development of a dual-target measles virus PCR assay and testing trends at a national reference laboratory.Journal of clinical microbiology · 2026Article
- Knowledge, attitudes and practices towards immunization among adult population in a tertiary care hospital-exploratory survey.Clinical and experimental vaccine research · 2026Article
- Strategies and distinguishing characteristics of faculty change agents teaching public health: a study on innovative teaching in higher education.Frontiers in public health · 2026Article
- Problem-Based Learning Case of Unvaccinated Child With Measles Infection: Integrating Viral Pathogenesis, Immunology, and Vaccine Ethics.MedEdPORTAL : the journal of teaching and learning resources · 2026Article
- Evaluating ChatGPT's responses to vaccine-related questions: the impact of question framing on content and quality.Translational pediatrics · 2025Article
- Assessing hesitancy towards paediatric vaccines among healthcare professionals: A descriptive cross-sectional study from the United Arab Emirates.Journal of public health research · 2025Article
- Socioeconomic Differences in Vaccination Coverage After a Mandatory Vaccination Law, 1855-1900.JAMA network open · 2025Article
- Pediatric Vaccine Hesitancy in the United States-The Growing Problem and Strategies for Management Including Motivational Interviewing.Vaccines · 2025Review
- Parental Vaccine Hesitancy, Awareness, and Attitudes Toward Childhood Vaccination in Saudi Arabia.Patient preference and adherence · 2025Article
- Time to first dose of measles-containing vaccine and associated factors among infants in Ethiopia: a survival analysis from performance monitoring for action data.Frontiers in public health · 2025Article
- Evaluation of knowledge, attitudes and vaccine hesitancy towards MMR vaccine among parents in the United Arab Emirates.PloS one · 2025Article
- Vaccination Hesitancy and Its Impact on Immunization Coverage in Pediatrics: A Systematic Review.Cureus · 2024Review
- Article
- Low Rates of Immunity among Medical Students and Residents in the Era of the Resurgence of Measles.Pathogens (Basel, Switzerland) · 2024Article
32 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Routine childhood vaccination is declining in some regions of the United States due to vaccine hesitancy, which risks the resurgence of many infectious diseases with public health and economic consequences. There are ongoing policy debates on the state and national level, including legislation around nonmedical (personal-belief) exemptions for childhood vaccination and possibly a special government commission on vaccine safety, which may affect vaccine coverage. Objective: To estimate the number of measles cases in US children and the associated economic costs under scenarios of different levels of vaccine hesitancy, using the case example of measles, mumps, and rubella (MMR) vaccination and measles. Design, Setting, and Participants: Publicly available data from the US Centers for Disease Control and Prevention were used to simulate county-level MMR vaccination coverage in children (age 2-11 years) in the United States. A stochastic mathematical model was adapted for infectious disease transmission that estimated a distribution for outbreak size as it relates to vaccine coverage. Economic costs per measles case were obtained from the literature. The predicted effects of increasing the prevalence of vaccine hesitancy as well as the removal of nonmedical exemptions were estimated. The model was calibrated to annual measles cases in US children over recent years, and the model prediction was validated using an independent data set from England and Wales. Main Outcomes and Measures: Annual measles cases in the United States and the associated public sector costs. Results: A 5% decline in MMR vaccine coverage in the United States would result in an estimated 3-fold increase in measles cases for children aged 2 to 11 years nationally every year, with an additional $2.1 million in public sector costs. The numbers would be substantially higher if unvaccinated infants, adolescents, and adult populations were also considered. There was variation around these estimates due to the stochastic elements of measles importation and sensitivity of some model inputs, although the trend was robust. Conclusions and Relevance: This analysis predicts that even minor reductions in childhood vaccination, driven by vaccine hesitancy (nonmedical and personal belief exemptions), will have substantial public health and economic consequences. The results support an urgent need to address vaccine hesitancy in policy dialogues at the state and national level, with consideration of removing personal belief exemptions of childhood vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.